Knight Therapeutics Inc.

OTCPK:KHTR.F Stock Report

Market Cap: US$579.5m

Knight Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:KHTR.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 May 26SellUS$244,517Robert LandeIndividual40,000US$6.12
26 Mar 26SellUS$50,566Cristiane Zanqueta Coelho PeevIndividual9,876US$5.12
23 Mar 26SellUS$36,843Henrique DiasIndividual7,734US$4.76
10 Dec 25BuyUS$13,326Jonathan GoodmanIndividual3,100US$4.30

Insider Trading Volume

Insider Buying: KHTR.F insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of KHTR.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies14,931,01315.2%
Individual Insiders23,011,80123.4%
Institutions24,315,53824.8%
General Public35,921,00936.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 63.22% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
22.2%
Jonathan Goodman
21,838,572US$128.9m0.21%no data
15.2%
Medici Strategic Portfolio Management Inc
14,931,013US$88.1m0%no data
12.8%
QV Investors Inc.
12,594,418US$74.3m386%2.57%
3.67%
Industrielle Alliance, Gestion de placements inc.
3,603,039US$21.3m0%0.18%
2.65%
Dimensional Fund Advisors LP
2,599,637US$15.3m0.76%no data
1.91%
Mawer Investment Management Ltd.
1,876,807US$11.1m0%0.03%
1.37%
Artisan Partners Limited Partnership
1,345,051US$7.9m0%0.01%
0.54%
Eaton Vance Management
534,840US$3.2m0%no data
0.45%
Samira Sakhia
446,199US$2.6m28.5%no data
0.41%
McElvaine Investment Management Ltd.
400,000US$2.4m0%10.38%
0.33%
Van Berkom and Associates Inc.
328,703US$1.9m0%0.06%
0.25%
Bessemer Investment Management LLC
246,614US$1.5m0%no data
0.23%
CI Global Asset Management
223,577US$1.3m-0.66%no data
0.21%
Robert Lande
203,178US$1.2m-16.5%no data
0.2%
Amal Khouri
198,810US$1.2m12.2%no data
0.17%
ATB Investment Management Inc.
164,925US$973.5k0%0.01%
0.11%
Arvind Utchanah
108,672US$641.5k54%no data
0.097%
Ampega Investment GmbH
95,200US$562.0k0%0.02%
0.086%
State Street Global Advisors, Inc.
84,098US$496.4k1.55%no data
0.054%
James Gale
52,997US$312.8k1.13%no data
0.054%
BlackRock, Inc.
52,764US$311.4k9.45%no data
0.049%
SLGI Asset Management Inc.
47,830US$282.3k0%0.01%
0.045%
Susan Emblem
44,360US$261.8k31.8%no data
0.029%
Manulife Asset Management
28,649US$169.1k0%no data
0.022%
Mônica Percario
21,203US$125.2k116%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/03 22:08
End of Day Share Price 2026/06/03 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Knight Therapeutics Inc. is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tania Armstrong-WhitworthATB Cormark Historical (Cormark Securities)
David KideckelBeacon Securities Limited
David MartinBloom Burton & Co.